DURECT (DRRX)
(Delayed Data from NSDQ)
$1.84 USD
-0.04 (-1.87%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $1.83 -0.01 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/12/2025
Time: -- |
6/2025 | $-0.13 | 0.00% |
Earnings Summary
For their last quarter, DURECT (DRRX) reported earnings of -$0.13 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for DRRX's next earnings release expected on August 12, 2025. For the next earning release, we expect the company to report earnings of -$0.13 per share, reflecting a year-over-year decrease of 8.33%.
Earnings History
Price & Consensus
Zacks News for DRRX
Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
DRRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Durect (DRRX) Reports Q4 Loss, Lags Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) Q4 Earnings and Revenues Beat Estimates
Stevanato Group (STVN) Meets Q4 Earnings Estimates
DRRX FAQs
Based on past history, Zacks believes DURECT Corporation (DRRX) will report their next quarter earnings on August 12, 2025. For the next earning release, we expect the company to report earnings of -0.13 per share, reflecting a year-over-year increase of -8.33.
Based on past history, Zacks believes DURECT Corporation (DRRX) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on August 12, 2025.
The Zacks Consensus Estimate for DURECT Corporation (DRRX) for the quarter ending June 2025 is $-0.13 a share. We expect DURECT Corporation (DRRX) to report earnings in line with the consensus estimate of $-0.13 per share
In the earnings report for the quarter ending in June 2024, DURECT Corporation (DRRX) announced earnings of $-0.12 per share versus the Zacks Consensus Estimate of $-0.17 per share, representing a surprise of -29.41%.